6 Recession Resistant Stocks With Over a 2% Dividend Yield

With the S&P 500 testing new all-time highs, the thought of a recession and a bear market is typically far from investors’ minds. However, being prepared with potentially good investments in a bearish climate is a way to be prepared as the market begins to top out. The fact these companies provide income in the form of dividends that are higher than the S&P 500 means that you get paid to wait or get money to hedge your positions. The following ...
Read More
|

Big Analyst Upgrade Has NIO Inc on the Rise and Option Traders Buying

Nio Inc (NYSE: NIO) found its share price rocketing higher on Tuesday as bulls jumped on the shares and levering up with long call options. The breakout came following a big turnaround by an analyst that has been a detractor for the company. While the upgrade and price target increase didn’t raise the bar any higher than it’s currently trading, it’s the change of heart that has led to the price surge and a recognition of the opportunity. China is ...
Read More
|

Insider Buying of this Company Indicates It’s More Than a Fish Farm

Aquabounty Technologies Inc (NASDAQ: AQB) raises bioengineered Atlantic salmon for human consumption. Raising salmon in Indiana and other inland locations may sound a little odd, but people do love their sushi. The company has shown improvement in their corporate earnings and has been able to gain needed financing. The recent surge in insider buying may be a clue as to the near-term potential for the company. In their most recent earnings press release, the company discussed their operation and ...
Read More
|
How can I double my money in 5 years?

How Can I Double My Money In 5 Years? A Guide to Compounding Wealth

On average, the stock market returns about 10 percent annually before inflation. While individual stocks can vary wildly, that beats the average returns against bonds or other asset classes. That’s especially true with annual interest rates back at zero percent. But here’s the beauty of that average return: If you keep your profits in the stock market, you can grow your wealth far faster than even that 10 percent figure. Why? Thanks to the power of compounding your initial investment, and with ...
Read More
|

7 Disruptive Companies for the Post-COVID World

As you consider the companies that dominate the market cap of the major market gauges, you may be wondering which companies are the titans of the future. While the following list likely doesn’t represent that type of life-changing potential, each of the seven companies represented have disruptive technology or concepts that are suited for a post-COVID world and the revenue and earnings expectations reflect that opportunity. According to Wikipedia, disruptive innovation “is an innovation that creates a new market and ...
Read More
|

It’s Earnings Week for Gap Inc and Option Traders are Lining Up

Gap Inc (NYSE: GPS) finished 7.42% higher on Monday as the stock is approaching earnings this week on August 27 after the market close. With such a bullish move ahead of an uncertain announcement, it appears that traders are looking forward to an earnings beat and upgraded guidance. Looking at the expected price move from the options market and Monday’s activity, the stock appears to be setting up for a dramatic move. With earnings coming up, it’s an important time ...
Read More
|

Kodiak Sciences is Looking Up After Monday’s Move and Last Week’s Insider Buy

Kodiak Sciences Inc (NASDAQ: KOD) saw its first significant insider transaction since March 18 last week. The transaction comes by a 10% owner, which is a good indication that they’re expecting the price to rise. The last purchase of consequence came near the March low before the stock went on a major run. After consolidating since mid-July the price finally broke out on Monday on increased volume. The breakout occurred two weeks after an earnings announcement that beat analyst expectations ...
Read More
|

10% Owner Has Just Resumed Buying as La Jolla Pharmaceuticals is Back at Support Again

La Jolla Pharmaceutical Company (NASDAQ: LJPC) hasn’t exactly been a stellar performer over the past three years. Over that period of time, the price has gone from around $40 to as low as $2.50. After two separate rallies off of this level, the price finds it back at the same point with Friday’s close of $3.84. As the price is stabilizing at this level, one director and 10% owner just added a significant amount to his holdings. The last earnings ...
Read More
|